Susha Dinesh
Research Subjects
Research Interests
Susha Dinesh has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Sameer Sharma
Department of Bioinformatics, BioNome, Bangalore, India
15 shared publications - Ashok Aspatwar
Tampere University
2 shared publications Dinesh Sosalagere Manjegowda
2 shared publications- Diya Bhalla
Department of Bioinformatics, BioNome, Bengaluru, Karnataka, 560043, India
2 shared publications Fathimathuz Zehra Waasia
Department of Bioinformatics, BioNome, Bengaluru, India
2 shared publicationsRajan Chourasiya
Department of Bioinformatics, BioNome, Bengaluru, 560043, India
2 shared publications
Latest Publications
- Open Access
- 28 February 2026
- Published by Springer Nature in Network Modeling Analysis in Health Informatics and Bioinformatics
- Vol. 15  (1)
Prognostic implications of TIMP1 gene expression in colon Adenocarcinoma: structural and functional consequences of non-synonymous SNP variants
The investigation into single nucleotide polymorphism (SNP) mutations within the TIMP1 gene, particularly in the context of colon cancer, is a topic of considerable scientific research. Numerous studies emphasize the pivotal role of TIMP1 in the promotion of tumorigenesis and metastasis in human colon cancer, positioning it as a potential prognostic marker and therapeutic target. Identifying polymorphisms influencing the structure and function of the TIMP1 gene is crucial. In this study, we pinpointed damaging non-synonymous SNPs (nsSNPs) among 2130 SNPs, with rs192373432 (R192W), rs145224385 (R203W), and rs199775125 (T171M) identified as deleterious, probably damaging, and exposed, respectively. Notably, the R203W substitution demonstrated the highest destabilizing effect (DDG value: -0.92872 Kcal/mol), indicating a more significant impact on protein stability than the other variants (R192W: -0.20284 Kcal/mol, T171M: -0.07699 Kcal/mol). Molecular dynamics simulations revealed that the R192W mutation results in a more rigid, compact, and structurally stable protein with reduced flexibility and fewer hydrogen bonds compared to the wild type, which might affect its functional interactions and stability. The 2D projection of the trajectory indicated that the mutant occupies a more constrained conformational space, reinforcing its rigid nature. The protein interaction network revealed associations with extracellular matrix remodeling (MMP1, MMP2, MMP3, MMP9, MMP10), inflammation (IL6, IL10), and immune response (CD63, FN1), offering insights into TIMP1’s potential mechanisms in colon cancer and identifying new therapeutic targets. Analysis of TIMP1 gene expression and survival in Colon Adenocarcinoma (COAD) unveiled a dual association, where both overexpression and downregulation of TIMP1 correlated with patient survival. Further research is essential to comprehensively understand the regulatory role of these genes on TIMP1 and their impact on colon cancer development and progression.
- 28 February 2026
- Published by Springer Nature in Network Modeling Analysis in Health Informatics and Bioinformatics
- Vol. 15  (1)
Open AccessPrognostic implications of TIMP1 gene expression in colon Adenocarcinoma: structural and functional consequences of non-synonymous SNP variants
The investigation into single nucleotide polymorphism (SNP) mutations within the TIMP1 gene, particularly in the context of colon cancer, is a topic of considerable scientific research. Numerous studies emphasize the pivotal role of TIMP1 in the promotion of tumorigenesis and metastasis in human colon cancer, positioning it as a potential prognostic marker and therapeutic target. Identifying polymorphisms influencing the structure and function of the TIMP1 gene is crucial. In this study, we pinpointed damaging non-synonymous SNPs (nsSNPs) among 2130 SNPs, with rs192373432 (R192W), rs145224385 (R203W), and rs199775125 (T171M) identified as deleterious, probably damaging, and exposed, respectively. Notably, the R203W substitution demonstrated the highest destabilizing effect (DDG value: -0.92872 Kcal/mol), indicating a more significant impact on protein stability than the other variants (R192W: -0.20284 Kcal/mol, T171M: -0.07699 Kcal/mol). Molecular dynamics simulations revealed that the R192W mutation results in a more rigid, compact, and structurally stable protein with reduced flexibility and fewer hydrogen bonds compared to the wild type, which might affect its functional interactions and stability. The 2D projection of the trajectory indicated that the mutant occupies a more constrained conformational space, reinforcing its rigid nature. The protein interaction network revealed associations with extracellular matrix remodeling (MMP1, MMP2, MMP3, MMP9, MMP10), inflammation (IL6, IL10), and immune response (CD63, FN1), offering insights into TIMP1’s potential mechanisms in colon cancer and identifying new therapeutic targets. Analysis of TIMP1 gene expression and survival in Colon Adenocarcinoma (COAD) unveiled a dual association, where both overexpression and downregulation of TIMP1 correlated with patient survival. Further research is essential to comprehensively understand the regulatory role of these genes on TIMP1 and their impact on colon cancer development and progression.
- 1 June 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmacogenomics and Personalized Medicine
- Vol. 22, 1-19
Computational Screening of Clinical Drug Libraries for Neurofibromin Inhibition: A Molecular Docking and Dynamics Study for Neurofibromatosis Therapy
Introduction: Neurofibromatosis type 1 (NF1) is a genetic disorder characterized by the development of benign tumors due to mutations in the NF1 gene, which encodes the tumor suppressor neurofibromin. This study aimed to identify novel inhibitors of neurofibromin through drug repurposing of clinical trial compounds from the Zinc15 database. Method: Utilizing advanced in silico techniques, we conducted molecular docking via PyRx and molecular dynamics simulations with GROMACS. Among the compounds analyzed, ZINC000261527152 (Tetrodotoxin) emerged as a promising candidate due to its binding affinity to NF1. Tetrodotoxin formed stable conventional and carbon-hydrogen bonds with key residues, including GLU 981, GLY 984, GLN 985, SER 1030, SER 1561, and ASN 1563. Molecular dynamics simulations confirmed the stability of the Tetrodotoxin- NF1 complex, with favorable RMSD, RMSF, radius of gyration (Rg), and solvent- accessible surface area (SASA) values over a 100 ns simulation period. Result: These results suggest that Tetrodotoxin could effectively inhibit neurofibromin, presenting a novel therapeutic approach for neurofibromatosis. However, despite the promising computational findings, further experimental validation through in vitro and in vivo studies is essential to confirm the efficacy and safety of Tetrodotoxin as a treatment for NF1. Conclusion: This research underscores the utility of computational drug repurposing methodologies and their role in accelerating the discovery of novel treatments for genetic disorders, particularly neurofibromatosis, thereby potentially improving patient outcomes and quality of life.
- 1 June 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmacogenomics and Personalized Medicine
- Vol. 22, 1-19
Computational Screening of Clinical Drug Libraries for Neurofibromin Inhibition: A Molecular Docking and Dynamics Study for Neurofibromatosis Therapy
Introduction: Neurofibromatosis type 1 (NF1) is a genetic disorder characterized by the development of benign tumors due to mutations in the NF1 gene, which encodes the tumor suppressor neurofibromin. This study aimed to identify novel inhibitors of neurofibromin through drug repurposing of clinical trial compounds from the Zinc15 database. Method: Utilizing advanced in silico techniques, we conducted molecular docking via PyRx and molecular dynamics simulations with GROMACS. Among the compounds analyzed, ZINC000261527152 (Tetrodotoxin) emerged as a promising candidate due to its binding affinity to NF1. Tetrodotoxin formed stable conventional and carbon-hydrogen bonds with key residues, including GLU 981, GLY 984, GLN 985, SER 1030, SER 1561, and ASN 1563. Molecular dynamics simulations confirmed the stability of the Tetrodotoxin- NF1 complex, with favorable RMSD, RMSF, radius of gyration (Rg), and solvent- accessible surface area (SASA) values over a 100 ns simulation period. Result: These results suggest that Tetrodotoxin could effectively inhibit neurofibromin, presenting a novel therapeutic approach for neurofibromatosis. However, despite the promising computational findings, further experimental validation through in vitro and in vivo studies is essential to confirm the efficacy and safety of Tetrodotoxin as a treatment for NF1. Conclusion: This research underscores the utility of computational drug repurposing methodologies and their role in accelerating the discovery of novel treatments for genetic disorders, particularly neurofibromatosis, thereby potentially improving patient outcomes and quality of life.
- 1 March 2025
- Published by Pleiades Publishing Ltd in Neurochemical Journal
- Vol. 19  (1) , 92-106
Investigating the Therapeutic Potential of Maharasnadi Kwath Constituents Against HTT Proteins in Huntington’s Disease: An In-Silico Pharmacological Approach
Huntington’s disease (HD) is a severe neurodegenerative disease marked by the progressive degradation of nerve cells in the brain, predominantly caused by Hutington gene (HTT) abnormalities. The objective of this study was to examine the possible therapeutic benefits of Maharasnadi Kwath, a conventional Ayurvedic formulation, by means of its interactions with the HTT protein in modifying the pathogenic mechanisms of HD. Using a computational methodology, we carried out in-silico pharmacological screenings and molecular docking studies to determine the binding affinities of Maharasnadi Kwath’s phytochemicals to these protein molecules. Employing the molecular docking software GROMACS, we identified multiple compounds in Maharasnadi Kwath that exhibited positive interactions. Substantial potential for therapeutic interaction was indicated by the docking scores for HTT proteins, which ranged from –4.8 to –9.8 kcal/mol. Molecular dynamics simulations (MDS) were utilized to validate the exceptionally high binding affinity of compound 14 106 342 to HTT (–9.8 kcal/mol). This facilitated the evaluation of the protein-compound complex stability over time. According to the findings, Maharasnadi Kwath may have an impact on important pathogenic pathways in HD, providing a foundation for further experimental research. The research emphasizes how important it is to conduct empirical validation in vivo and in vitro in order to validate these computational predictions and assess the phytochemicals’ potential therapeutic value in Maharasnadi Kwath. Subsequent investigations ought to broaden to examine the influence of the formulation on additional molecular pathways impacted by HD and evaluate its general effectiveness and safety profile in clinical contexts.
- 1 March 2025
- Published by Pleiades Publishing Ltd in Neurochemical Journal
- Vol. 19  (1) , 92-106
Investigating the Therapeutic Potential of Maharasnadi Kwath Constituents Against HTT Proteins in Huntington’s Disease: An In-Silico Pharmacological Approach
Huntington’s disease (HD) is a severe neurodegenerative disease marked by the progressive degradation of nerve cells in the brain, predominantly caused by Hutington gene (HTT) abnormalities. The objective of this study was to examine the possible therapeutic benefits of Maharasnadi Kwath, a conventional Ayurvedic formulation, by means of its interactions with the HTT protein in modifying the pathogenic mechanisms of HD. Using a computational methodology, we carried out in-silico pharmacological screenings and molecular docking studies to determine the binding affinities of Maharasnadi Kwath’s phytochemicals to these protein molecules. Employing the molecular docking software GROMACS, we identified multiple compounds in Maharasnadi Kwath that exhibited positive interactions. Substantial potential for therapeutic interaction was indicated by the docking scores for HTT proteins, which ranged from –4.8 to –9.8 kcal/mol. Molecular dynamics simulations (MDS) were utilized to validate the exceptionally high binding affinity of compound 14 106 342 to HTT (–9.8 kcal/mol). This facilitated the evaluation of the protein-compound complex stability over time. According to the findings, Maharasnadi Kwath may have an impact on important pathogenic pathways in HD, providing a foundation for further experimental research. The research emphasizes how important it is to conduct empirical validation in vivo and in vitro in order to validate these computational predictions and assess the phytochemicals’ potential therapeutic value in Maharasnadi Kwath. Subsequent investigations ought to broaden to examine the influence of the formulation on additional molecular pathways impacted by HD and evaluate its general effectiveness and safety profile in clinical contexts.
- Top Cited PapersOpen Access
- 20 January 2025
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 61  (1) , 1-27
Inside the impulsive brain: a narrative review on the role of neurobiological, hormonal and genetic factors influencing impulsivity in psychiatric disorders
This abstract delves into the intricate nature of impulsivity and its ramifications across psychiatric disorders, leveraging advancements in neuroimaging and psychological studies. It elucidates diverse facets of impulsivity, encompassing response, choice, and tendencies, emphasizing its pivotal role in executive functioning and social development. The intricate interplay of hormonal influences, specifically cortisol, adrenaline, and testosterone, is meticulously examined, unveiling associations between elevated cortisol levels, excessive adrenaline release, and heightened impulsivity. The ventromedial prefrontal cortex (VMPFC) assumes a central role in decision-making and emotional regulation, demonstrating correlations with conditions, such as antisocial behavior and mood disorders. Substantial contributions from neurotransmitters like dopamine and serotonin to impulsive behavior underscore the imperative need for genetic and neurochemical investigations to identify factors crucial for effective management. Interconnections between stress, impulsivity, and decision-making are accentuated, particularly in mood disorders. Hormones, such as leptin and ghrelin, in conjunction with the hypothalamic–pituitary–adrenal axis, play pivotal roles in conditions like major depressive disorder. Concurrently, leptin resistance exerts influence over appetite and mood regulation. The nexus between impulsivity and substance use disorders emphasizes the intricate involvement of neurobiological, neurotransmitter, and genetic components, guiding targeted interventions. Recognition of gender-specific impulsive behaviors and hormonal influences is imperative for tailoring treatment plans. Advocating a comprehensive approach that integrates hormonal assessments with clinical evaluations, taking into account the neurobiological context, is essential. While serotonin systems show promise for treating impulsive aggressiveness, challenges encompass intricate hormonal interactions, ethical considerations, limited treatment options, and the necessity for individualized approaches. Addressing these intricacies is pivotal for advancing knowledge and formulating effective interventions for Impulsive Control Disorders.
- 20 January 2025
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 61  (1) , 1-27
Top Cited PapersOpen AccessInside the impulsive brain: a narrative review on the role of neurobiological, hormonal and genetic factors influencing impulsivity in psychiatric disorders
This abstract delves into the intricate nature of impulsivity and its ramifications across psychiatric disorders, leveraging advancements in neuroimaging and psychological studies. It elucidates diverse facets of impulsivity, encompassing response, choice, and tendencies, emphasizing its pivotal role in executive functioning and social development. The intricate interplay of hormonal influences, specifically cortisol, adrenaline, and testosterone, is meticulously examined, unveiling associations between elevated cortisol levels, excessive adrenaline release, and heightened impulsivity. The ventromedial prefrontal cortex (VMPFC) assumes a central role in decision-making and emotional regulation, demonstrating correlations with conditions, such as antisocial behavior and mood disorders. Substantial contributions from neurotransmitters like dopamine and serotonin to impulsive behavior underscore the imperative need for genetic and neurochemical investigations to identify factors crucial for effective management. Interconnections between stress, impulsivity, and decision-making are accentuated, particularly in mood disorders. Hormones, such as leptin and ghrelin, in conjunction with the hypothalamic–pituitary–adrenal axis, play pivotal roles in conditions like major depressive disorder. Concurrently, leptin resistance exerts influence over appetite and mood regulation. The nexus between impulsivity and substance use disorders emphasizes the intricate involvement of neurobiological, neurotransmitter, and genetic components, guiding targeted interventions. Recognition of gender-specific impulsive behaviors and hormonal influences is imperative for tailoring treatment plans. Advocating a comprehensive approach that integrates hormonal assessments with clinical evaluations, taking into account the neurobiological context, is essential. While serotonin systems show promise for treating impulsive aggressiveness, challenges encompass intricate hormonal interactions, ethical considerations, limited treatment options, and the necessity for individualized approaches. Addressing these intricacies is pivotal for advancing knowledge and formulating effective interventions for Impulsive Control Disorders.
- 19 December 2024
- Published by Springer Nature in Biotechnology Letters
- Vol. 47  (1) , 1-20
Comparative proteomic analysis to annotate the structural association of the hypothetical proteins from the conserved domain of P. aeruginosa as novel vaccine candidates
Objectives Pseudomonas aeruginosa, identified as an ESKAPE pathogen, contributes to severe clinical diseases worldwide and despite its prevalence an effective vaccine or treatment remains elusive. Numerous computational methods are being employed to target hypothetical proteins (HPs). Presently, no studies have predicted multi-epitope vaccines for these HPs. Results Totally, 877 HPs from P. aeruginosa were included in the study and the data showcased here illustrate a methodical approach to prioritize the proteome by employing diverse comparative proteomics. The study employed physicochemical property assessment and conserved domain analysis to identify stable and immunologically pertinent proteins for epitope prediction. The VaxiJen2.0 antigenicity assessment aided in epitope selection, contributing to the foundational steps in vaccine development by predicting T-cell and B-cell epitopes. Potential T and B cell epitopes with high antigenicity, non-toxic categorization, and robust binding affinities were identified in the investigation. The periplasmic HP WP_132813935.1 was predicted as conserved, stable, and soluble. The T-cell peptide RTSMRALAY and the B-cell peptide MPVYLYLM were predicted to be probable non-allergen and demonstrated strong binding with MHC class I allele HLA-C*03:03. Conclusions This research provides a comprehensive approach to predict T and B cell epitopes for conditions associated with P. aeruginosa, offering a candidate pool for tailored vaccine development. However, the efficacy of these epitopes in vaccine development necessitates clinical validation and testing for confirmation.
- 19 December 2024
- Published by Springer Nature in Biotechnology Letters
- Vol. 47  (1) , 1-20
Comparative proteomic analysis to annotate the structural association of the hypothetical proteins from the conserved domain of P. aeruginosa as novel vaccine candidates
Objectives Pseudomonas aeruginosa, identified as an ESKAPE pathogen, contributes to severe clinical diseases worldwide and despite its prevalence an effective vaccine or treatment remains elusive. Numerous computational methods are being employed to target hypothetical proteins (HPs). Presently, no studies have predicted multi-epitope vaccines for these HPs. Results Totally, 877 HPs from P. aeruginosa were included in the study and the data showcased here illustrate a methodical approach to prioritize the proteome by employing diverse comparative proteomics. The study employed physicochemical property assessment and conserved domain analysis to identify stable and immunologically pertinent proteins for epitope prediction. The VaxiJen2.0 antigenicity assessment aided in epitope selection, contributing to the foundational steps in vaccine development by predicting T-cell and B-cell epitopes. Potential T and B cell epitopes with high antigenicity, non-toxic categorization, and robust binding affinities were identified in the investigation. The periplasmic HP WP_132813935.1 was predicted as conserved, stable, and soluble. The T-cell peptide RTSMRALAY and the B-cell peptide MPVYLYLM were predicted to be probable non-allergen and demonstrated strong binding with MHC class I allele HLA-C*03:03. Conclusions This research provides a comprehensive approach to predict T and B cell epitopes for conditions associated with P. aeruginosa, offering a candidate pool for tailored vaccine development. However, the efficacy of these epitopes in vaccine development necessitates clinical validation and testing for confirmation.
- Open Access
APV9WR: An Integrated Web Resource of Alpha papillomavirus 9 for Genomics, Proteomics, Phylogenetic and Therapeutic Analysis
Purpose: Alphapapillomavirus 9 is a virus belonging to the Papillomaviridae family. It has a close genetic relationship with high-risk HPV-16 and other HPV strains such as HPV-31, HPV-52, HPV-35, HPV-58, HPV-67, and HPV-35. This virus is responsible for causing warts and malignant tumors and is responsible for about 75% of cervical malignancies and pre-cancerous lesions worldwide. As a result, it requires specialized research and attention. Our goal is to create a comprehensive resource that can assist researchers and scientific groups in their work. Material and Methodology: A total of 1230 full genome sequences and 9140 protein sequences were obtained from GenBank and NCBI Virus, respectively. Further Phylogenetic Analysis, Codon usage and context analysis, CpG islands analysis, Glycosylation sites, Diagnostic Primers, B cell Epitopes and MHC I and MHC II binders were identified and analyzed using relevant Bioinformatics tools and Python program Results: APV9WR is a web resource that was developed after analysis. Our data indicate that HPV 35 and HPV 38 have the most genomic diversity. From codon usage analysis, it was observed that AAA, AUU, UAU, UGU, and UUU are the most used codons, while ACG, CCG, CGA, CGG, CGU, GCG, and UCG are some of the unusual codons in APV9 nucleotide sequence with accession id - LC626346.1 . We found 4714 CpG island locations in 1230 complete nucleotide sequences of APV9, and only 663 CpG island locations were unique. Further N-linked glycosylation, O-linked glycosylation, diagnostic primers, Potential B-cell epitopes and MHC I and MHC II binders were also analyzed and tabulated. Conclusion: We have consolidated basic information about the virus, such as entire genomic sequences and proteins. It primarily comprises a wide range of studies and outcomes, including genome alignment, phylogenetic inferences, codon context and usage bias, and important CpG island statistics. Furthermore, primers for molecular diagnostics were identified, and glycosylation sites were located and investigated. Most significantly, potential therapeutic elements such as vaccine epitopes and obtaining potential information about them were investigated. Our collective effort on this tool is meant to serve the greater good of the research community for therapeutic intervention for Alphapapillomavirus 9. Using this link https://apv9nsut.web.app will take you to the web app.
Open AccessAPV9WR: An Integrated Web Resource of Alpha papillomavirus 9 for Genomics, Proteomics, Phylogenetic and Therapeutic Analysis
Purpose: Alphapapillomavirus 9 is a virus belonging to the Papillomaviridae family. It has a close genetic relationship with high-risk HPV-16 and other HPV strains such as HPV-31, HPV-52, HPV-35, HPV-58, HPV-67, and HPV-35. This virus is responsible for causing warts and malignant tumors and is responsible for about 75% of cervical malignancies and pre-cancerous lesions worldwide. As a result, it requires specialized research and attention. Our goal is to create a comprehensive resource that can assist researchers and scientific groups in their work. Material and Methodology: A total of 1230 full genome sequences and 9140 protein sequences were obtained from GenBank and NCBI Virus, respectively. Further Phylogenetic Analysis, Codon usage and context analysis, CpG islands analysis, Glycosylation sites, Diagnostic Primers, B cell Epitopes and MHC I and MHC II binders were identified and analyzed using relevant Bioinformatics tools and Python program Results: APV9WR is a web resource that was developed after analysis. Our data indicate that HPV 35 and HPV 38 have the most genomic diversity. From codon usage analysis, it was observed that AAA, AUU, UAU, UGU, and UUU are the most used codons, while ACG, CCG, CGA, CGG, CGU, GCG, and UCG are some of the unusual codons in APV9 nucleotide sequence with accession id - LC626346.1 . We found 4714 CpG island locations in 1230 complete nucleotide sequences of APV9, and only 663 CpG island locations were unique. Further N-linked glycosylation, O-linked glycosylation, diagnostic primers, Potential B-cell epitopes and MHC I and MHC II binders were also analyzed and tabulated. Conclusion: We have consolidated basic information about the virus, such as entire genomic sequences and proteins. It primarily comprises a wide range of studies and outcomes, including genome alignment, phylogenetic inferences, codon context and usage bias, and important CpG island statistics. Furthermore, primers for molecular diagnostics were identified, and glycosylation sites were located and investigated. Most significantly, potential therapeutic elements such as vaccine epitopes and obtaining potential information about them were investigated. Our collective effort on this tool is meant to serve the greater good of the research community for therapeutic intervention for Alphapapillomavirus 9. Using this link https://apv9nsut.web.app will take you to the web app.
- 1 May 2024
- Published by Bentham Science Publishers Ltd. in Current Diabetes Reviews
- Vol. 20  (5) , 1-22
From Gut to Glucose: A Comprehensive Review on Functional Foods and Dietary Interventions for Diabetes Management
Background:: In the realm of diabetes research, considerable attention has been directed toward elucidating the intricate interplay between the gastrointestinal tract and glucose regulation. The gastrointestinal tract, once exclusively considered for its role in digestion and nutrient assimilation, is presently acknowledged as a multifaceted ecosystem with regulatory supremacy over metabolic homeostasis and glucose metabolism. Recent studies indicate that alterations in the composition and functionality of the gut microbiota could potentially influence the regulation of glucose levels and glucose homeostasis in the body. Dysbiosis, characterized by perturbations in the equilibrium of gut microbial constituents, has been irrevocably linked to an augmented risk of diabetes mellitus (DM). Moreover, research has revealed the potential influence of the gut microbiota on important factors, like inflammation and insulin sensitivity, which are key contributors to the onset and progression of diabetes. The key protagonists implicated in the regulation of glucose encompass the gut bacteria, gut barrier integrity, and the gut-brain axis. A viable approach to enhance glycemic control while concurrently mitigating the burden of comorbidities associated with diabetes resides in the strategic manipulation of the gut environment through adapted dietary practices. Objective:: This review aimed to provide a deep understanding of the complex relationship between gut health, glucose metabolism, and diabetes treatment. Conclusion:: This study has presented an exhaustive overview of dietary therapies and functional foods that have undergone extensive research to explore their potential advantages in the management of diabetes. It looks into the role of gut health in glucose regulation, discusses the impact of different dietary elements on the course of diabetes, and evaluates how well functional foods can help with glycemic control. Furthermore, it investigates the mechanistic aspects of these therapies, including their influence on insulin sensitivity, β-cell activity, and inflammation. It deliberates on the limitations and potential prospects associated with integrating functional foods into personalized approaches to diabetes care.
- 1 May 2024
- Published by Bentham Science Publishers Ltd. in Current Diabetes Reviews
- Vol. 20  (5) , 1-22
From Gut to Glucose: A Comprehensive Review on Functional Foods and Dietary Interventions for Diabetes Management
Background:: In the realm of diabetes research, considerable attention has been directed toward elucidating the intricate interplay between the gastrointestinal tract and glucose regulation. The gastrointestinal tract, once exclusively considered for its role in digestion and nutrient assimilation, is presently acknowledged as a multifaceted ecosystem with regulatory supremacy over metabolic homeostasis and glucose metabolism. Recent studies indicate that alterations in the composition and functionality of the gut microbiota could potentially influence the regulation of glucose levels and glucose homeostasis in the body. Dysbiosis, characterized by perturbations in the equilibrium of gut microbial constituents, has been irrevocably linked to an augmented risk of diabetes mellitus (DM). Moreover, research has revealed the potential influence of the gut microbiota on important factors, like inflammation and insulin sensitivity, which are key contributors to the onset and progression of diabetes. The key protagonists implicated in the regulation of glucose encompass the gut bacteria, gut barrier integrity, and the gut-brain axis. A viable approach to enhance glycemic control while concurrently mitigating the burden of comorbidities associated with diabetes resides in the strategic manipulation of the gut environment through adapted dietary practices. Objective:: This review aimed to provide a deep understanding of the complex relationship between gut health, glucose metabolism, and diabetes treatment. Conclusion:: This study has presented an exhaustive overview of dietary therapies and functional foods that have undergone extensive research to explore their potential advantages in the management of diabetes. It looks into the role of gut health in glucose regulation, discusses the impact of different dietary elements on the course of diabetes, and evaluates how well functional foods can help with glycemic control. Furthermore, it investigates the mechanistic aspects of these therapies, including their influence on insulin sensitivity, β-cell activity, and inflammation. It deliberates on the limitations and potential prospects associated with integrating functional foods into personalized approaches to diabetes care.
- 17 April 2024
- Published by Taylor & Francis in Systems Biology in Reproductive Medicine
- Vol. 70  (1) , 101-112
Prediction of deleterious non-synonymous SNPs of human MDC1 gene: an in silico approach
MDC1 (Mediator of DNA damage Checkpoint protein 1) functions to facilitate the localization of numerous DNA damage response (DDR) components to DNA double-strand break sites. MDC1 is an integral component in preserving genomic stability and appropriate DDR regulation. There haven't been systematic investigations of MDC1 mutations that induce cancer and genomic instability. Variations in nsSNPs have the potential to modify the protein chemistry and their function. Describing functional SNPs in disease-associated genes presents a significant conundrum for investigators, it is possible to assess potential functional SNPs before conducting larger population examinations. Multiple sequences and structure-based bioinformatics strategies were implemented in the current in-silico investigation to discern potential nsSNPs of the MDC1 genes. The nsSNPs were identified with SIFT, SNAP2, Align GVGD, PolyPhen-2, and PANTHER, and their stability was determined with MUpro. The conservation, solvent accessibility, and structural effects of the mutations were identified with ConSurf, NetSurfP-2.0, and SAAFEC-SEQ respectively. Cancer-related analysis of the nsSNPs was conducted using cBioPortal and TCGA web servers. The present study appraised five nsSNPs (P1426T, P69S, P194R, P203L, and H131Y) as probably mutilating due to their existence in highly conserved regions and propensity to deplete protein stability. The nsSNPs P194R, P203L, and H131Y were concluded as deleterious and possibly damaging from the 5 prediction tools. The functional nsSNP P194R mutation is associated with skin cutaneous melanoma while no significant records were found for other nsSNPs. The present study concludes that the highly deleterious P194R mutations can potentially induce genomic instability and contribute to various cancers' pathogenesis. Developing drugs targeting these mutations can undoubtedly be advantageous in large population-based studies, particularly in the development of precision medicine.
- 17 April 2024
- Published by Taylor & Francis in Systems Biology in Reproductive Medicine
- Vol. 70  (1) , 101-112
Prediction of deleterious non-synonymous SNPs of human MDC1 gene: an in silico approach
MDC1 (Mediator of DNA damage Checkpoint protein 1) functions to facilitate the localization of numerous DNA damage response (DDR) components to DNA double-strand break sites. MDC1 is an integral component in preserving genomic stability and appropriate DDR regulation. There haven't been systematic investigations of MDC1 mutations that induce cancer and genomic instability. Variations in nsSNPs have the potential to modify the protein chemistry and their function. Describing functional SNPs in disease-associated genes presents a significant conundrum for investigators, it is possible to assess potential functional SNPs before conducting larger population examinations. Multiple sequences and structure-based bioinformatics strategies were implemented in the current in-silico investigation to discern potential nsSNPs of the MDC1 genes. The nsSNPs were identified with SIFT, SNAP2, Align GVGD, PolyPhen-2, and PANTHER, and their stability was determined with MUpro. The conservation, solvent accessibility, and structural effects of the mutations were identified with ConSurf, NetSurfP-2.0, and SAAFEC-SEQ respectively. Cancer-related analysis of the nsSNPs was conducted using cBioPortal and TCGA web servers. The present study appraised five nsSNPs (P1426T, P69S, P194R, P203L, and H131Y) as probably mutilating due to their existence in highly conserved regions and propensity to deplete protein stability. The nsSNPs P194R, P203L, and H131Y were concluded as deleterious and possibly damaging from the 5 prediction tools. The functional nsSNP P194R mutation is associated with skin cutaneous melanoma while no significant records were found for other nsSNPs. The present study concludes that the highly deleterious P194R mutations can potentially induce genomic instability and contribute to various cancers' pathogenesis. Developing drugs targeting these mutations can undoubtedly be advantageous in large population-based studies, particularly in the development of precision medicine.
- 1 April 2024
- Published by Bentham Science Publishers Ltd. in Central Nervous System Agents in Medicinal Chemistry
- Vol. 24  (1) , 2-21
Bridging the Mind and Gut: Uncovering the Intricacies of Neurotransmitters, Neuropeptides, and their Influence on Neuropsychiatric Disorders
Background:: The gut-brain axis (GBA) is a bidirectional signaling channel that facilitates communication between the gastrointestinal tract and the brain. Recent research on the gut-brain axis demonstrates that this connection enables the brain to influence gut function, which in turn influences the brain and its cognitive functioning. It is well established that malfunctioning of this axis adversely affects both systems' ability to operate effectively. Objective:: Dysfunctions in the GBA have been associated with disorders of gut motility and permeability, intestinal inflammation, indigestion, constipation, diarrhea, IBS, and IBD, as well as neuropsychiatric and neurodegenerative disorders like depression, anxiety, schizophrenia, autism, Alzheimer's, and Parkinson's disease. Multiple research initiatives have shown that the gut microbiota, in particular, plays a crucial role in the GBA by participating in the regulation of a number of key neurochemicals that are known to have significant effects on the mental and physical well-being of an individual. Methods:: Several studies have investigated the relationship between neuropsychiatric disorders and imbalances or disturbances in the metabolism of neurochemicals, often leading to concomitant gastrointestinal issues and modifications in gut flora composition. The interaction between neurological diseases and gut microbiota has been a focal point within this research. The novel therapeutic interventions in neuropsychiatric conditions involving interventions such as probiotics, prebiotics, and dietary modifications are outlined in this review. Results:: The findings of multiple studies carried out on mice show that modulating and monitoring gut microbiota can help treat symptoms of such diseases, which raises the possibility of the use of probiotics, prebiotics, and even dietary changes as part of a new treatment strategy for neuropsychiatric disorders and their symptoms. Conclusion:: The bidirectional communication between the gut and the brain through the gut-brain axis has revealed profound implications for both gastrointestinal and neurological health. Malfunctions in this axis have been connected to a range of disorders affecting gut function as well as cognitive and neuropsychiatric well-being. The emerging understanding of the role of gut microbiota in regulating key neurochemicals opens up possibilities for novel treatment approaches for conditions like depression, anxiety, and neurodegenerative diseases.
- 1 April 2024
- Published by Bentham Science Publishers Ltd. in Central Nervous System Agents in Medicinal Chemistry
- Vol. 24  (1) , 2-21
Bridging the Mind and Gut: Uncovering the Intricacies of Neurotransmitters, Neuropeptides, and their Influence on Neuropsychiatric Disorders
Background:: The gut-brain axis (GBA) is a bidirectional signaling channel that facilitates communication between the gastrointestinal tract and the brain. Recent research on the gut-brain axis demonstrates that this connection enables the brain to influence gut function, which in turn influences the brain and its cognitive functioning. It is well established that malfunctioning of this axis adversely affects both systems' ability to operate effectively. Objective:: Dysfunctions in the GBA have been associated with disorders of gut motility and permeability, intestinal inflammation, indigestion, constipation, diarrhea, IBS, and IBD, as well as neuropsychiatric and neurodegenerative disorders like depression, anxiety, schizophrenia, autism, Alzheimer's, and Parkinson's disease. Multiple research initiatives have shown that the gut microbiota, in particular, plays a crucial role in the GBA by participating in the regulation of a number of key neurochemicals that are known to have significant effects on the mental and physical well-being of an individual. Methods:: Several studies have investigated the relationship between neuropsychiatric disorders and imbalances or disturbances in the metabolism of neurochemicals, often leading to concomitant gastrointestinal issues and modifications in gut flora composition. The interaction between neurological diseases and gut microbiota has been a focal point within this research. The novel therapeutic interventions in neuropsychiatric conditions involving interventions such as probiotics, prebiotics, and dietary modifications are outlined in this review. Results:: The findings of multiple studies carried out on mice show that modulating and monitoring gut microbiota can help treat symptoms of such diseases, which raises the possibility of the use of probiotics, prebiotics, and even dietary changes as part of a new treatment strategy for neuropsychiatric disorders and their symptoms. Conclusion:: The bidirectional communication between the gut and the brain through the gut-brain axis has revealed profound implications for both gastrointestinal and neurological health. Malfunctions in this axis have been connected to a range of disorders affecting gut function as well as cognitive and neuropsychiatric well-being. The emerging understanding of the role of gut microbiota in regulating key neurochemicals opens up possibilities for novel treatment approaches for conditions like depression, anxiety, and neurodegenerative diseases.
- 27 March 2024
- Published by Springer Nature in In Silico Pharmacology
- Vol. 12  (1) , 1-15
Computational screening of damaging nsSNPs in human SOD1 genes associated with amyotrophic lateral sclerosis identifies destabilising effects of G38R and G42D mutations through in silico evaluation
Amyotrophic lateral sclerosis (ALS), a complicated neurodegenerative disorder affected by hereditary and environmental variables, is a condition. In this study, the genetic makeup of ALS is investigated, with a focus on the SOD1 gene’s single-nucleotide polymorphisms (SNPs) and their ability to affect disease risk. Eleven high-risk missense variations that may impair the functionality of the SOD1 protein were discovered after a thorough examination of SNPs in the SOD1 gene. These mutations were chosen using a variety of prediction approaches, highlighting their importance in the aetiology of ALS. Notably, it was discovered that the stability of the SOD1 wild-type protein structure was compromised by the G38R and G42D SOD1 variants. Additionally, Edaravone, a possible ALS medication, showed a greater affinity for binding mutant SOD1 structures, pointing to potential personalised treatment possibilities. The high-risk SNPs discovered in this investigation seem to have functional effects, especially on the stability of proteins and their interactions with other molecules. This study clarifies the complex genetics of ALS and offers insights into how these genetic variations may affect the effectiveness of therapeutic interventions, particularly in the context of edaravone. In this study advances our knowledge of the genetic mechanisms causing ALS vulnerability and prospective therapeutic strategies. Future studies are necessary to confirm these results and close the gap between individualised clinical applications and improved ALS care.
- 27 March 2024
- Published by Springer Nature in In Silico Pharmacology
- Vol. 12  (1) , 1-15
Computational screening of damaging nsSNPs in human SOD1 genes associated with amyotrophic lateral sclerosis identifies destabilising effects of G38R and G42D mutations through in silico evaluation
Amyotrophic lateral sclerosis (ALS), a complicated neurodegenerative disorder affected by hereditary and environmental variables, is a condition. In this study, the genetic makeup of ALS is investigated, with a focus on the SOD1 gene’s single-nucleotide polymorphisms (SNPs) and their ability to affect disease risk. Eleven high-risk missense variations that may impair the functionality of the SOD1 protein were discovered after a thorough examination of SNPs in the SOD1 gene. These mutations were chosen using a variety of prediction approaches, highlighting their importance in the aetiology of ALS. Notably, it was discovered that the stability of the SOD1 wild-type protein structure was compromised by the G38R and G42D SOD1 variants. Additionally, Edaravone, a possible ALS medication, showed a greater affinity for binding mutant SOD1 structures, pointing to potential personalised treatment possibilities. The high-risk SNPs discovered in this investigation seem to have functional effects, especially on the stability of proteins and their interactions with other molecules. This study clarifies the complex genetics of ALS and offers insights into how these genetic variations may affect the effectiveness of therapeutic interventions, particularly in the context of edaravone. In this study advances our knowledge of the genetic mechanisms causing ALS vulnerability and prospective therapeutic strategies. Future studies are necessary to confirm these results and close the gap between individualised clinical applications and improved ALS care.